AI Can Draft a Review Response. It Should Never Publish One.

AI makes the easy part of review management easier. It can collect comments, group recurring themes, route urgent cases, and draft a polite first version of a response. It can also make the dangerous part dangerously fast: a privacy breach, an invented fact, or an inappropriate reply can move from prompt to public page without a person stopping it.

The right model for healthcare is supervised assistance, not autopilot. AI prepares work. A trained human decides whether to publish, revise, escalate, or say nothing.

Start with a review policy, not a tool

Before connecting any system to a review profile, define the practice’s rules. Who owns the queue? What counts as a clinical-safety, privacy, billing, legal, or threat issue? Which approved channel should a response direct someone to? Who may see review data, and which systems may receive it?

This foundation matters because the risk is not limited to the words eventually published. Copying a review into an unapproved AI service, enriching it with chart facts, or connecting an automation to patient records can create privacy and security exposure before a response exists. A vendor’s willingness to sign a business associate agreement may be relevant when it handles protected health information, but a BAA is not a substitute for minimum-necessary data practices, access controls, configuration, and workforce training. Start with the practice’s broader HIPAA marketing fundamentals, then have privacy and security owners assess the actual workflow.

For most public-review drafting, the safest input is the minimum needed: the public review text, stripped of unnecessary identifiers, with no chart lookup added to the prompt. The drafting instruction should forbid confirming patient status, repeating clinical or billing details, making promises, or arguing disputed facts.

The human approval gate is not optional

Sentiment labels and draft replies can save staff time, but they are not reliable enough to carry professional accountability. An AI system cannot know whether a complaint hints at patient harm, whether a name identifies the wrong person, whether a seemingly harmless detail is protected, or whether silence is more appropriate.

A workable queue has four outcomes:

• approve or lightly edit a low-risk response;
• rewrite a draft that is generic, defensive, or inaccurate;
• escalate a safety, privacy, legal, billing, discrimination, or threat concern; or
• publish nothing and handle the matter through an approved private process.

No output should bypass that gate. Disable automatic publishing. Limit publishing permission to trained staff. Keep a record of the final approved copy and the approver, without turning the review system into a repository of clinical details.

This is more than cautious style. HHS’s Office for Civil Rights resolved a case involving a provider that disclosed protected health information while responding to a negative review. The Manasa Health Center resolution makes the practical boundary clear: a reviewer’s public disclosure does not make it safe for a covered provider to confirm the relationship or discuss the person’s care.

What a safe public response can—and cannot—do

A public reply can acknowledge that the practice takes a type of concern seriously and offer an approved route for private follow-up. It should not confirm that the person visited, describe treatment, correct their medical narrative, quote the record, explain an account balance, or reveal that staff tried to call them. Even “we reviewed your chart” confirms more than a public response should.

For example, imagine a review that says, “They ignored my symptoms after the procedure and never called back.” An AI draft might apologize for “the delay in postoperative follow-up.” That polished phrase adopts facts and confirms a care relationship. A trained reviewer should replace it with something narrower: “We take concerns about timely communication seriously. Please contact our practice manager through [approved channel] so the appropriate team can review the matter.” Meanwhile, any possible safety issue should move immediately through the practice’s clinical escalation process. The public answer and the internal response are different jobs.

Human review also prevents false warmth. Referencing specific details from a positive review may sound personal, but in healthcare it can echo information that should not be amplified. Gratitude can be genuine without restating the service received.

AI cannot make a fake review authentic

The FTC’s Consumer Reviews and Testimonials Rule prohibits businesses from creating or selling fake reviews and, when the business knew or should have known they were fake or false, from buying certain reviews or disseminating fake testimonials. The FTC expressly includes reviews attributed to people who do not exist or who did not have the represented experience; generative AI does not create an exception. The FTC’s official rule announcement summarizes those prohibitions.

A real patient may independently use a writing tool to organize their own thoughts. That fact alone does not show the underlying experience is false. But the practice should not compose a review for the patient, hand them glowing copy, manufacture a persona, or instruct them what rating to leave. The most defensible request remains neutral: invite a genuine account, in the patient’s own chosen meaning, without screening for praise.

Incentives require equally precise language. Google Maps prohibits incentivized reviews and selectively soliciting positive reviews. Google’s specific incentivized or biased reviews policy is stricter than a common shorthand about FTC law. The FTC’s rule does not categorically ban every incentive; it prohibits incentives conditioned expressly or implicitly on a particular sentiment, while FTC guidance also addresses disclosure and broader deception risk. The FTC review-rule Q&A explains the distinction. For Google reviews, the practical decision is simple: offer no incentive. For other uses, confirm the platform, federal, state, professional, and payer rules before acting. This is operational guidance, not legal advice. Our fuller review-strategy guide covers fair solicitation.

When a review looks fake

AI has lowered the cost of creating plausible fiction, but a practice should not claim it can reliably identify a fake from writing style. Awkward language is not proof; polished language is not proof either.

Preserve the URL, date, screenshots, and the specific reasons the account appears inconsistent with a genuine experience. Report it through the platform’s process. If there is coordinated harassment, impersonation, extortion, or a credible threat, route the evidence to counsel or the appropriate authority. Do not publicly identify or accuse the reviewer without a sound factual and legal basis, and do not answer suspected manipulation with purchased reviews or a sudden campaign designed to bury it.

Use AI to make judgment more consistent

The most valuable automation is often unglamorous. It can tag access complaints, produce a weekly theme summary, flag drafts containing risky terms, and remind the right owner that a case is waiting. Those uses help a human team see patterns without pretending the model is a compliance officer.

Review themes can then inform real decisions: staffing the phones differently, clarifying estimates, changing a handoff, or repairing a confusing intake step. They can also inform testimonial work, but publishing patient stories requires a separate consent and substantiation process; see our guide to patient testimonial consent.

The standard is not whether the AI sounds human. It is whether the practice remains accountable for every input, decision, and public word. Let the model draft. Keep the judgment—and the publish button—with a person.

---

Need to design a supervised review workflow? Talk with Decabrand about routing, approval, and privacy-safe response standards.